Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$95 Mln
Revenue (TTM)
$17 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.3 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.4
Industry P/E
--
EV/EBITDA
1.7
Div. Yield
0 %
Debt to Equity
0.1
Book Value
$4.5
EPS
$-1.3
Face value
--
Shares outstanding
56,420,772
CFO
$-204.74 Mln
EBITDA
$-317.85 Mln
Net Profit
$-297.13 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Seer Inc (SEER)
| -7.1 | -1.2 | -7.1 | 2.4 | -23.9 | -49.6 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Seer Inc (SEER)
| -20.8 | 18.9 | -66.6 | -74.6 | -59.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Seer Inc (SEER)
|
1.7 | 94.8 | 16.6 | -73.6 | -442.7 | -25.1 | -- | 0.4 |
| 46.7 | 10,201.5 | 6,708.0 | 373.9 | 7.8 | 8.7 | 29.7 | 2.5 | |
| 11.0 | 537.3 | 52.8 | -22.9 | -15.3 | -49 | -- | 7.8 | |
| 1,259.9 | 25,364.5 | 4,026.4 | 869.2 | 27.7 | -1154.9 | 29.7 | 1,328.2 | |
| 215.5 | 9,407.2 | 1,005.3 | 136.8 | 15.2 | 6.8 | 68.1 | 4.7 | |
| 13.7 | 524.4 | 455.6 | -84.5 | -16.6 | -10 | -- | 0.7 | |
| 11.0 | 1,747.6 | 1,892.6 | 144.7 | 15.5 | -21 | 12.9 | 9.6 | |
| 186.8 | 12,927.2 | 62,508.1 | 827.7 | 2.3 | 10 | 15.8 | 1.5 | |
| 0.0 | 0.0 | 9.6 | -14.8 | -40.7 | -493.8 | -- | 0.0 | |
| 1.3 | 164.0 | 7,022.0 | -1,029.0 | -6.9 | -105.6 | -- | 0.4 |
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph... Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Address: 3800 Bridge Parkway, Redwood City, CA, United States, 94065 Read more
Founder, CEO, & Chair of the Board of Directors
Dr. Omid C. Farokhzad M.D., Ph.D.
Founder, CEO, & Chair of the Board of Directors
Dr. Omid C. Farokhzad M.D., Ph.D.
Headquarters
Redwood City, CA
Website
The share price of Seer Inc (SEER) is $1.70 (NASDAQ) as of 02-Apr-2026 16:00 EDT. Seer Inc (SEER) has given a return of -23.92% in the last 3 years.
Since, TTM earnings of Seer Inc (SEER) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-1.42
|
0.40
|
|
2024
|
-1.65
|
0.44
|
|
2023
|
-1.44
|
0.31
|
|
2022
|
-3.87
|
0.80
|
|
2021
|
-19.55
|
2.77
|
The 52-week high and low of Seer Inc (SEER) are Rs 2.41 and Rs 1.62 as of 03-Apr-2026.
Seer Inc (SEER) has a market capitalisation of $ 95 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Seer Inc (SEER), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.